EVER Pharma GmbH
- Legal form
- GmbH
- Seat
- Gröbenzell, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 22 September 2026.
Identifiers
Not found in the indexed notices.
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | €1,000 | 1 | 0 | 22 September 2026 | 22 September 2026 |
Awards
- Pantoprazol 2026Buyer: Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH und der AGKAMED GmbH · Award value: €1,000 excl. VAT · Awarded: 22 September 2026 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
Not found in the indexed notices.
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Infliximab, in der Wirkstärke 120mg, ATC L04AB02
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Raloxifen, ATC G03XC01
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Infliximab, ausgenommen in der Wirkstärke 120mg, ATC L04AB02
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Epinephrin, ausgenommen in der nasalen Darreichungsform, ATC C01CA24
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Lopinavir und Ritonavir, ATC J05AR10
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Testosteron, ausgenommen in der Darreichungsform Injektionslösung, ATC G03BA03
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Nevirapin, ATC J05AG01
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Sorafenib, ATC L01EX02
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Etanercept, ATC L04AB01
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open house Arzneimittelrabattverträge Naproxen, ATC M01AE02
Reasons
- Won a contract in CPV group 336 (2026-09-22) Evidence · checked 7 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 22 September 2026.